compounded semaglutide crackdown news today The market for GLP-1 drugs remained robust despite the end of (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) shortages, with many facilities adding ingredients like B vitamins and some operating with The growing availability of compounded

But the actual weight inside those vials told a different story

FDA: Approval of Zepbound (tirzepatide) for weight management

Nystrom T, Gutniak MK, Zhang Q, Zhang F, Holst JJ, Ahren B, Sjoholm A: Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease

Also, growing awareness about the risk of obesity to health is supporting to enhancement of weight loss, including these medications

In addition, weight loss medications are generally not prescribed for patients with eating disorders, and, therefore, patients should be screened for these conditions

The tirzepatide compound first came to market under the name Mounjaro, and it is a glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 in one single molecule